Concepedia

Eva A. Ebbing

EA

Statistics

Publications

7

Citations

421

H-Index

7

Active since

2015

Affiliations

Amsterdam UMC Location University of Amsterdam(Current)

Amsterdam University Medical Centers

University of Amsterdam

Oncode Institute

Amsterdam University of Applied Sciences

Eva A. Ebbing is an author at Amsterdam UMC Location University of Amsterdam specializing in molecular oncology, oncology, and medicine.

Publications per year

2015–2019

7

Publications

7

Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma

Eva A. Ebbing, Amber P. van der Zalm, Anne Steins et al. · Proceedings of the National Academy of Sciences · 2019 · 198 citations · Full text

, , +17

Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract

Helene Damhofer, Eva A. Ebbing, Anne Steins et al. · Journal of Translational Medicine · 2015 · 79 citations · Full text

, , +15

Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition

Eva A. Ebbing, Anne Steins, Evelyn Fessler et al. · Gastroenterology · 2017 · 41 citations

, , +17

ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3

Eva A. Ebbing, Jan Paul Medema, Helene Damhofer et al. · Oncotarget · 2016 · 34 citations · Full text

, , +13

Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma

Anne Steins, Eva A. Ebbing, Aafke Creemers et al. · International Journal of Cancer · 2019 · 32 citations · Full text

, , +17

1–5 of 7